262 related articles for article (PubMed ID: 24607207)
21. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
[TBL] [Abstract][Full Text] [Related]
22. The effects of iontophoresis and electroporation on transdermal delivery of buprenorphine from solutions and hydrogels.
Fang JY; Sung KC; Wang JJ; Chu CC; Chen KT
J Pharm Pharmacol; 2002 Oct; 54(10):1329-37. PubMed ID: 12396293
[TBL] [Abstract][Full Text] [Related]
23. Optimization of ibuprofen gel formulations using experimental design technique for enhanced transdermal penetration.
Rhee YS; Chang SY; Park CW; Chi SC; Park ES
Int J Pharm; 2008 Nov; 364(1):14-20. PubMed ID: 18755258
[TBL] [Abstract][Full Text] [Related]
24. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery.
Donnelly RF; Garland MJ; Alkilani AZ
Methods Mol Biol; 2014; 1141():121-32. PubMed ID: 24567135
[TBL] [Abstract][Full Text] [Related]
25. Transdermal drug delivery enhanced and controlled by erbium:YAG laser: a comparative study of lipophilic and hydrophilic drugs.
Lee WR; Shen SC; Lai HH; Hu CH; Fang JY
J Control Release; 2001 Jul; 75(1-2):155-66. PubMed ID: 11451505
[TBL] [Abstract][Full Text] [Related]
26. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
[TBL] [Abstract][Full Text] [Related]
27. Transdermal absorption of memantin--effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity.
del Rio-Sancho S; Serna-Jiménez CE; Calatayud-Pascual MA; Balaguer-Fernández C; Femenía-Font A; Merino V; López-Castellano A
Eur J Pharm Biopharm; 2012 Sep; 82(1):164-70. PubMed ID: 22732268
[TBL] [Abstract][Full Text] [Related]
28. Construction of a quantitative structure-permeability relationship (QSPR) for the transdermal delivery of NSAIDs.
Liou YB; Ho HO; Yang CJ; Lin YK; Sheu MT
J Control Release; 2009 Sep; 138(3):260-7. PubMed ID: 19467276
[TBL] [Abstract][Full Text] [Related]
29. Peptide dendrimer-conjugates of ketoprofen: Synthesis and ex vivo and in vivo evaluations of passive diffusion, sonophoresis and iontophoresis for skin delivery.
Hegde AR; Rewatkar PV; Manikkath J; Tupally K; Parekh HS; Mutalik S
Eur J Pharm Sci; 2017 May; 102():237-249. PubMed ID: 28285173
[TBL] [Abstract][Full Text] [Related]
30. Improving ex vivo skin permeation of non-steroidal anti-inflammatory drugs: enhancing extemporaneous transformation of liposomes into planar lipid bilayers.
Vázquez-González ML; Bernad R; Calpena AC; Domènech O; Montero MT; Hernández-Borrell J
Int J Pharm; 2014 Jan; 461(1-2):427-36. PubMed ID: 24361268
[TBL] [Abstract][Full Text] [Related]
31. Design of original bioactive formulations based on sugar-surfactant/non-steroidal anti-inflammatory catanionic self-assemblies: a new way of dermal drug delivery.
Consola S; Blanzat M; Perez E; Garrigues JC; Bordat P; Rico-Lattes I
Chemistry; 2007; 13(11):3039-47. PubMed ID: 17285653
[TBL] [Abstract][Full Text] [Related]
32. Effect of terpenes on transdermal iontophoretic delivery of diclofenac potassium under constant voltage.
Arunkumar S; Shivakumar HN; Narasimha Murthy S
Pharm Dev Technol; 2018 Oct; 23(8):806-814. PubMed ID: 28814142
[TBL] [Abstract][Full Text] [Related]
33. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
[TBL] [Abstract][Full Text] [Related]
34. Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal antiinflammatory drugs.
Friedman DI; Schwarz JS; Weisspapir M
J Pharm Sci; 1995 Mar; 84(3):324-9. PubMed ID: 7616372
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical studies of binary eutectic of ibuprofen and ketoprofen for enhanced transdermal drug delivery.
Yuan X; Capomacchia AC
Drug Dev Ind Pharm; 2010 Oct; 36(10):1168-76. PubMed ID: 20367290
[TBL] [Abstract][Full Text] [Related]
36. Novel nanostructured supramolecular hydrogels for the topical delivery of anionic drugs.
Limón D; Amirthalingam E; Rodrigues M; Halbaut L; Andrade B; Garduño-Ramírez ML; Amabilino DB; Pérez-García L; Calpena AC
Eur J Pharm Biopharm; 2015 Oct; 96():421-36. PubMed ID: 26409201
[TBL] [Abstract][Full Text] [Related]
37. Interaction of ibuprofen and indomethacin with caffeine.
Khalil RM
Pharmazie; 1996 Dec; 51(12):970-3. PubMed ID: 8985985
[TBL] [Abstract][Full Text] [Related]
38. Effect of DC/mDC iontophoresis and terpenes on transdermal permeation of methotrexate: in vitro study.
Prasad R; Koul V; Anand S; Khar RK
Int J Pharm; 2007 Mar; 333(1-2):70-8. PubMed ID: 17116378
[TBL] [Abstract][Full Text] [Related]
39. Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.
Velázquez C; Praveen Rao PN; Knaus EE
J Med Chem; 2005 Jun; 48(12):4061-7. PubMed ID: 15943479
[TBL] [Abstract][Full Text] [Related]
40. Formulation of hydrogel-thickened nonionic microemulsions with enhanced percutaneous delivery of ibuprofen assessed in vivo in rats.
Djekic L; Martinovic M; Stepanović-Petrović R; Micov A; Tomić M; Primorac M
Eur J Pharm Sci; 2016 Sep; 92():255-65. PubMed ID: 27157041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
